Improving early clinical drug development for neuropathic pain by improving patient selection

Pain

Volumn 141, Issue 1-2, 2009, Pages 4-5

  Segerdahl, Märta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG RESEARCH; EDITORIAL; NEUROPATHIC PAIN; PAIN ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL;

ANALGESICS; DRUG EVALUATION; HUMANS; NEURALGIA; PATIENT SELECTION;

EID: 58149260205     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.11.003     Document Type: Editorial

References (8)

1. Bennett M.I., Smith B.H., Torrance N., and Lee A.J. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 122 (2006) 289-294
2. Colloca L., and Benedetti F. How prior experience shapes placebo analgesia. Pain 124 (2006) 126-133
3. Gruener G., and Dyck P.J. Quantitative sensory testing: methodology, applications, and future directions. J Clin Neurophysiol 11 (1994) 568-583
4. Ho T.W., Backonja M., Ma J., Leibensperger H., Froman S., and Polydefkis M. Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies. Pain 141 (2009) 19-24
5. Melzack R. The short-form McGill Pain Questionnaire. Pain 30 (1987) 191-197
6. Nebuchennykh M., Loseth S., Stalberg E., and Mellgren S.I. Quantitative sensory testing in patients with polyneuropathy and healthy individuals. Acta Neurol Scand Suppl 188 (2008) 56-61
7. Periquet M.I., Novak V., Collins M.P., Nagaraja H.N., Erdem S., Nash S.M., et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 53 (1999) 1641-1647
8. Santiago S., Ferrer T., and Espinosa M.L. Neurophysiological studies of thin myelinated (A delta) and unmyelinated (C) fibers: application to peripheral neuropathies. Neurophysiol Clin 30 (2000) 27-42